Abstract:Abstract Introduction Traumatic brain injuries (TBI) can cause persistent sleep dysregulation regardless of injury severity including hypersomnia, hyposmia, sleepiness, sleep fragmentation, and altered electroencephalogram (EEG) power spectra. Most TBIs are mild in severity, occur in the frontal cortex, and sleep dysregulation can change over time. Orexin targets two receptors that stimulate monoamine release in the brain to promote wakefulness. Our goal was to determine if a dual orexin receptor antagonist (DORA) could improve sleep dysregulation in mice with TBI. Methods Two-month-old male and female C57BL/6J mice were randomly assigned to treatment groups. Mice underwent polysomnography surgery. After recovery, mice were administered vehicle by gavage then underwent baseline sleep recordings for 24 h followed by a multiple sleep latency test (MSLT). Mice received a craniectomy and mild/moderate TBI via controlled cortical impact or only a craniectomy serving as a control. A DORA or vehicle were given by gavage, and sleep and MSLT were recorded 24 h, 2 wks, 1 m, and 2 m post-TBI. Sleep state amounts and episode durations and frequencies, sleep latency, and EEG power spectra (0-40 Hz) were determined with significance set at p< 0.05. Results In mice given the DORA or vehicle, non-rapid-eye movement (NREM) sleep was significantly increased 24 h after TBI compared to controls. Conversely, NREM sleep was significantly reduced 2 m post-TBI in both vehicle and DORA groups. DORA and/or TBI groups had significantly reduced waking episodes 24 h post-injury but increased waking episodes 2 m post-TBI compared to controls indicating sleep fragmentation. Largely, significantly increased sleep latency time in the MSLT was found throughout all times post-injury in the DORA and TBI groups compared to the controls, which suggests increased sleepiness. Relative to controls, TBI significantly increased EEG delta power (0.5-4 Hz) 24 h post-TBI and significantly reduced EEG delta power 2 m post-TBI, although other frequency bands were not affected. Conclusion These data suggest that a DORA induces sleepiness but has minimal effects on impaired sleep amounts, sleep fragmentation, sleepiness, and EEG power spectra 2 m after mild/moderate TBI. Support (if any) Merit Review Award (I01BX005379)(MRZ) and SPiRE Award (I21RX003722)(GBK) Department of Veterans Affairs

The Role of the Orexin System in Craniocerebral Trauma-Induced Epilepsy in Mice

RNA Sequencing Analysis of Cortex and Hippocampus in a Kainic Acid Rat Model of Temporal Lobe Epilepsy to Identify Mechanisms and Therapeutic Targets Related to Inflammation, Immunity and Cognition.

Medial prefrontal cortex oxytocin mitigates epilepsy and cognitive impairments induced by traumatic brain injury through reducing neuroinflammation in mice

Orexin A alleviates neuroinflammation via OXR2/CaMKKβ/AMPK signaling pathway after ICH in mice

Orexin-A exerts neuroprotective effect in experimental intracerebral hemorrhage by suppressing autophagy via OXR1-mediated ERK/mTOR signaling pathway

Epilepsy Alters the Expression of C-FOS Protein in Hippocampus and Cortex of Parietal Lobe of Adult Mice Insulted by Traumatic Injury

Early hippocampal high-amplitude rhythmic spikes predict post-traumatic epilepsy in mice

Neuroprotective effects of naltrexone in a mouse model of post-traumatic seizures

Therapeutic effects of orexin-A in sepsis-associated encephalopathy in mice

Orexin-A inhibits cerebral ischaemic inflammatory injury mediated by the nuclear factor-κB signalling pathway and alleviates stroke-induced immunodepression in mice

Oxytocin alleviates cognitive and memory impairments by decreasing hippocampal microglial activation and synaptic defects via OXTR/ERK/STAT3 pathway in a mouse model of sepsis-associated encephalopathy

A role of dentate gyrus mechanistic target of rapamycin activation in epileptogenesis in a mouse model of posttraumatic epilepsy

0049 Sleep and Electroencephalogram Effects from a Dual Orexin Receptor Antagonist in Mice with Traumatic Brain Injury

Orexin-A protects against cerebral ischemia-reperfusion injury by inhibiting excessive autophagy through OX1R-mediated MAPK/ERK/mTOR pathway

Wake-promoting actions of median nerve stimulation in TBI-induced coma: An investigation of orexin-A and orexin receptor 1 in the hypothalamic region

Role of orexin-A in experimental autoimmune encephalomyelitis

Orexin A improves the cognitive impairment induced by chronic intermittent hypoxia in mice

Median Nerve Stimulation Attenuates Traumatic Brain Injury-Induced Comatose State by Regulating the Orexin-A/RasGRF1 Signaling Pathway

Atypical Neurogenesis, Astrogliosis, and Excessive Hilar Interneuron Loss Are Associated with the Development of Post-Traumatic Epilepsy

Orexin-A alleviates astrocytic apoptosis and inflammation via inhibiting OX1R-mediated NF-κB and MAPK signaling pathways in cerebral ischemia/reperfusion injury